$40.22 0.73 (+1.85%)
12/3/2009 4:00 PM

Vertex Pharmaceuticals, Inc. (VRTX)

CAPS Rating: 3 out of 5

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases.

Recs

2
Member Avatar genedom (36.09) Submitted: 9/27/2007 2:45:18 AM : Underperform Start Price: $37.99 VRTX Score: -30.24

A 5-billion dollar company with the drug approval two years away is too pricey for me. Not mention anything can happen in phase III trial.

Report this Post 0 Comments

Featured Broker Partners